Nouvelle déclaration d'incident
No de la demande: 2017-4037
Numéro de référence du titulaire d'homologation: USA-BAYERBAH-2017-US0013263
Nom du titulaire (nom légal complet, aucune abbréviation): Bayer inc
Adresse: 2920 Matheson Blvd
Ville: Mississaugua
État: ON
Pays: Canada
Code postal /Zip: L4W 5R6
Incident chez un animal domestique
Pays: UNITED STATES
État: UNKNOWN
Inconnu
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. Inconnu
Nom du produit: Seresto Dog Collar unknown
Autre (préciser)
CollarOui
Inconnu
Site: Animal / Usage sur un animal domestique
Inconnu
Propriétaire de l'animal
Dog / Chien
Golden Retriever
1
Inconnu
Inconnu
Inconnu
Cutanée
Unknown / Inconnu
Unknown / Inconnu
Système
Unknown / Inconnu
Inconnu
Inconnu
Mort
Other / Autre
préciser Unknown
(p.ex. description des symptômes tels que la fréquence et la gravité
On an unknown date in 2016, a Retriever (Golden) canine, of unknown signalment, in unknown condition, with no known concomitant medical conditions, had 1 Seresto Dog (unspecified)(Flumethrin-Imidacloprid) collar placed around the neck by the owner. On an unknown date post application in 2016, the canine was examined by a veterinarian and was diagnosed with an unspecified neoplasia. It was unknown if any treatments were performed. On an unknown date post application, in 2016, the canine died. No known necropsy was performed. Due to the sensitive nature of the communication, specific relevant event details were not obtained, nor will such be sought. The reason for the initial phone call was to discuss the use of the product and not to report the death of the patient. No further information expected. This case is closed.
Mort
N - Unlikely The reported serious sign such as unspecified neoplasia associated with death of the animal not expected following appropriate topical product application as inconsistent with products pharmacological profile. Oral exposure to the collar is not expected to cause such signs either. An overdose of 5 collars around the neck was investigated in adult cats and dogs for an 8 months period and in 10 week old kittens and 7 week old puppies for a 6 months period without causing serious signs. Fatal outcome was likely consequence of unspecified neoplasia and thus, sufficient information exists to rule out product involvement. Moreover, the owner did not believe in product involvement either as the reason for initial call was to discuss the use of the product and not to report the death of the patient. Although no necropsy performed, a product involvement is considered unlikely.